Effectiveness and safety of sacubitril/valsartan in patients with stage 4 chronic kidney disease in a real-world population

被引：0
|
作者：
Joana Brito, J. [1 ]
Agostinho, J. [1 ]
Pereira, S. [1 ]
Rodrigues, T. [1 ]
Nunes-Ferreira, A. [1 ]
Silverio-Antonio, P. [1 ]
Rigueira, J. [1 ]
Silva, D. [1 ]
Pinto, Fausto [1 ]
Brito, D. [1 ]
机构：
[1] Santa Maria Univ Hosp, CHLN Lisbon Acad Med Ctr, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [21] REAL-WORLD USE OF SACUBITRIL-VALSARTAN IN THE SOUTH OF ENGLAND
    Dimarco, Anthony
    Haydock, Paul
    Flett, Andrew
    Cowburn, Peter
    Chandrasekaran, Badrinathan
    Foley, Paul
    Dixon, Giles
    Jackson, Thomas
    Critoph, Chris
    Davis, Hannah
    Kelly, Dominic
    [J]. HEART, 2020, 106 : A72 - A73
  • [22] Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure
    Correale, Michele
    Tricarico, Lucia
    Ferraretti, Armando
    Formica, Ennio S.
    Padovano, Giuseppina
    Monaco, Ilenia
    Merolla, Giuseppina
    Tozzi, Valeria
    Di Biase, Matteo
    Iacoviello, Massimo
    Brunetti, Natale Daniele
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (06) : 508 - 510
  • [23] Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance
    Yee Soo Kim
    Simerjeet Brar
    Natalie D’Albo
    Amit Dey
    Sachin Shah
    Sarju Ganatra
    Sourbha S. Dani
    [J]. Cardiovascular Drugs and Therapy, 2022, 36 : 915 - 924
  • [24] Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
    Maria Vincenza Polito
    Angelo Silverio
    Antonella Rispoli
    Gennaro Vitulano
    Federica D’ Auria
    Elena De Angelis
    Francesco Loria
    Alberto Gigantino
    Domenico Bonadies
    Rodolfo Citro
    Albino Carrizzo
    Gennaro Galasso
    Guido Iaccarino
    Carmine Vecchione
    Michele Ciccarelli
    [J]. Scientific Reports, 10
  • [25] HEALTH OUTCOMES PROJECTIONS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE IN A REAL-WORLD POPULATION IN PORTUGAL
    Afonso-Silva, M.
    Laires, P. A.
    [J]. VALUE IN HEALTH, 2019, 22 : S547 - S548
  • [26] Effects of Sacubitril/Valsartan in real-world HF and reduced ejection fraction (HFrEF) population.
    Polito, M.
    Vitulano, G.
    Rispoli, A.
    D'auria, F.
    Gigantino, A.
    Citro, R.
    Bonadies, D.
    Iaccarino, G.
    Ciccarelli, M. Michele
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 238 - 238
  • [27] Effect of sacubitril/valsartan therapy on risk stratification biomarkers in a real-world heart failure population
    Barrett, M. J.
    Hammond, M.
    Zhou, S.
    Hanlon, R. O.
    Campbell, P.
    Mcdonald, K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 585 - 586
  • [28] Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
    Polito, Maria Vincenza
    Silverio, Angelo
    Rispoli, Antonella
    Vitulano, Gennaro
    D'Auria, Federica
    De Angelis, Elena
    Loria, Francesco
    Gigantino, Alberto
    Bonadies, Domenico
    Citro, Rodolfo
    Carrizzo, Albino
    Galasso, Gennaro
    Iaccarino, Guido
    Vecchione, Carmine
    Ciccarelli, Michele
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] Beneficial Effects of Sacubitril/Valsartan at Low Doses in an Asian Real-World Heart Failure Population
    Hu, Jingwen
    Wu, Yucheng
    Zhou, Xiujuan
    Wang, Xiaozhi
    Jiang, Wanying
    Huo, Junyu
    Shan, Qijun
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (04) : 445 - 451
  • [30] REAL-WORLD IMPACT OF SACUBITRIL/VALSARTAN ON THE QUALITY OF LIFE OF HEART FAILURE PATIENTS IN PORTUGAL
    Afonso Nogueira, M.
    Afonso-Silva, M.
    Gomes, M.
    Andreozzi, V
    Vandewalle, B.
    Costa Ferreira, F.
    Monica, L.
    Cruz, L.
    Guimaraes, M.
    Proenca, G.
    [J]. VALUE IN HEALTH, 2020, 23 : S504 - S505
12345